Hypomethylation and increased gene expression of p16(INK4a) in primary and metastatic breast carcinoma as compared to normal breast tissue

Oncogene

Volumn 16, Issue 21, 1998, Pages 2723-2727

  Van Zee, Kimberly J ^a   Calvano, Jacqueline E ^a   Bisogna, Maria ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Expression; Methylation; Normal breast tissue; p16(INK4a)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; MESSENGER RNA; PROTEIN P16;

ARTICLE; BREAST; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL;

EID: 0032575010     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201794     Document Type: Article

References (25)

1. Antequera F and Bird A. (1993). Proc. Natl. Acad. Sci. USA, 90, 11995-11999.
2. Arap W, Nishikawa R, Furnari FB, Cavenee WK and Huang HJS. (1995). Cancer Res., 55, 1351-1354.
3. Baylin SB. (1992). AIDS Research and Human Retroviruses, 5, 811-820.
4. Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH and Aldaz CM. (1996). Clin. Cancer Res., 2, 1993-1998.
5. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE and Sidransky D. (1994). Science, 265, 415-417.
6. Calvano JE, Rush EB, Tan LK, Rosen PP, Borgen PI and Van Zee KJ. (1997). Ann. Surg. Oncol., 4, 416-420.
7. Costello JF, Berger MS, Huang H-JS and Cavenee WK. (1996). Cancer Res., 56, 2405-2410.
8. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
9. Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP. (1985). Science, 228, 187-190.
10. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA. (1995). Cancer Res., 55, 4531-4535.
11. Hebert J, Cayuela JM, Berkeley J and Sigaux F. (1994). Blood, 84, 4038-4044.
12. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Suan D-SR, Gnarra JR, Linehan WM and Baylin SB. (1994). Proc. Natl. Acad. Sci. USA, 91, 9700-9704.
13. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB. (1995). Cancer Res., 55, 4525-4530.
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RSI, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
15. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686-692.
16. Mohandas T, Sparkes RS and Shapiro LJ. (1981). Science, 211, 393-396.
17. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
18. Olopade OI, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM and Diaz MO. (1992). Genomics, 14, 437-443.
19. Peter M and Herskowitz I. (1994). Cell, 79, 181-184.
20. Rush EB, Abouezzi Z, Borgen PI and Anelli A. (1995). Cancer Letters, 89, 223-226.
21. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
22. Spruck III CH, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin M-F, Gonzales F, Tsai YC and Jones PA. (1994). Nature, 370, 183-184.
23. Stöger R, Kubicka P, Liu C-G, Kafri T, Raxin A, Cedar H and Barlow DP. (1993). Cell, 73, 61-71.
24. Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN, Gusella JF and Ramesh V. (1994). Cancer Res., 54, 5262-5264.
25. Zariwala M, Liu E and Xiong Y. (1996). Oncogene, 12, 451-455.